Vigilant Capital Management’s Franklin Genomic Advancements ETF HELX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-900	Closed	-$27K	–	470
2022 Q4	$27K	Buy	+900	New	+$27K	﹤0.01%	314